News from veracyte, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jul 03, 2014, 07:30 ET

Veracyte Announces Positive Coverage Policies for Afirma® Gene Expression Classifier from Highmark Inc. and Horizon Blue Cross Blue Shield of New Jersey

 Veracyte, Inc., a molecular diagnostics company pioneering the field of molecular cytology, today announced that two Blue Cross Blue Shield...

Jun 23, 2014, 07:30 ET

Veracyte Comments On Preliminary American Thyroid Association Guidelines Regarding Thyroid Nodule Management

 Veracyte, Inc. (Nasdaq: VCYT), a molecular diagnostics company pioneering the field of molecular cytology, today commented on preliminary...

Jun 18, 2014, 07:30 ET

Veracyte to Present at JMP Securities 2014 Healthcare Conference

 Veracyte, Inc. (Nasdaq: VCYT) today announced that Bonnie H. Anderson, president and chief executive officer, will present at the JMP...

Jun 16, 2014, 07:30 ET

Veracyte Named a 2014 "Top Workplace" in the San Francisco Bay Area

 Veracyte, Inc. (Nasdaq: VCYT), a molecular diagnostics company pioneering the field of molecular cytology, today announced that it has been...

Jun 03, 2014, 07:30 ET

Veracyte to Present at 2014 William Blair Growth Stock Conference

 Veracyte, Inc. (Nasdaq: VCYT) today announced that Bonnie H. Anderson, president and chief executive officer, will present at the 2014 William...

May 28, 2014, 07:30 ET

Veracyte to Present at Jefferies 2014 Global Healthcare Conference

 Veracyte, Inc. (Nasdaq: VCYT) today announced that Bonnie H. Anderson, president and chief executive officer, will present at the Jefferies...

May 20, 2014, 11:15 ET

Veracyte Presents Preliminary Data for Molecular Classifier to Improve Early, Non-Surgical Diagnosis of Idiopathic Pulmonary Fibrosis

Veracyte, Inc. (Nasdaq: VCYT) announced the presentation of the first proof-of-concept data demonstrating the company's ability to develop a...

May 13, 2014, 07:30 ET

Veracyte, Inc. Launches Afirma® Malignancy Classifiers to Further Help Thyroid Nodule Patients Avoid Unnecessary Surgeries and Lower Healthcare Costs

 Veracyte, Inc. (Nasdaq: VCYT) today announced the launch of its Afirma Malignancy Classifiers to further establish the Afirma Thyroid FNA...

May 08, 2014, 16:05 ET

Veracyte, Inc. Announces First Quarter 2014 Financial Results

Veracyte, Inc. (Nasdaq: VCYT) today reported financial results for the first quarter ended March 31, 2014, and provided an update on recent...

May 07, 2014, 07:30 ET

Preliminary Data Supporting Veracyte Molecular Classifier for Idiopathic Pulmonary Fibrosis (IPF) Diagnosis to be Presented at ATS 2014

Veracyte, Inc. (Nasdaq: VCYT) announced that early data demonstrating the company's ability to develop a molecular classifier differentiating...

May 06, 2014, 07:30 ET

New Data Validating Veracyte's Afirma® Malignancy Classifiers to be Presented at AACE Congress

 Veracyte, Inc. (Nasdaq: VCYT) today announced that four abstracts supporting the use of the company's Afirma Malignancy Classifiers and...

May 02, 2014, 07:30 ET

Veracyte and Fleury Announce Partnership to Make the Afirma® Gene Expression Classifier Available to Patients in Brazil

 Veracyte, Inc. (Nasdaq: VCYT) and Fleury Medicine and Health today announced a new partnership that will make Veracyte's Afirma Gene...

May 01, 2014, 07:30 ET

Veracyte, Inc. to Host Conference Call and Webcast to Discuss First Quarter 2014 Financial Results on May 8, 2014

 Veracyte, Inc. (Nasdaq: VCYT) announced today that its first quarter 2014 financial results will be released after close of market on...

Mar 18, 2014, 16:05 ET

Veracyte, Inc. Announces Fourth Quarter and Full-Year 2013 Financial Results, Provides 2014 Financial Outlook

Veracyte, Inc. (Nasdaq: VCYT) today reported financial results and business progress for the quarter and full year ended December 31, 2013, and...

Mar 17, 2014, 07:30 ET

Veracyte, Inc. Appoints Julie A. Brooks as Executive Vice President, General Counsel and Secretary; and Andy Thorson as Executive Vice President, Corporate Strategy and Business Development

Veracyte, Inc. (Nasdaq: VCYT), a molecular diagnostics company pioneering the field of molecular cytology, today announced the appointments of two...

Mar 11, 2014, 07:30 ET

Veracyte, Inc. to Announce Fourth Quarter and Full-Year 2013 Financial Results and Host Conference Call on Tuesday, March 18, 2014

Veracyte, Inc. (Nasdaq: VCYT) announced today that it will release its fourth quarter and full-year 2013 financial results after close of market on...

Mar 03, 2014, 13:27 ET

Veracyte Updates Presentation Date and Time at the Cowen and Company 34th Annual Health Care Conference

Veracyte, Inc. (Nasdaq: VCYT) today announced a change in the company's presentation date and time at the Cowen and Company 34th Annual Health Care...

Feb 26, 2014, 07:30 ET

Veracyte to Present at Cowen and Company 34th Annual Health Care Conference

 Veracyte, Inc. (Nasdaq: VCYT) today announced that Bonnie H. Anderson, president and chief executive officer, will present at the Cowen and...

Feb 05, 2014, 07:30 ET

Veracyte To Present At 2014 Leerink Global Healthcare Conference

 Veracyte, Inc. (Nasdaq: VCYT) today announced that Bonnie H. Anderson, president and chief executive officer, will present at the 2014 Leerink...

Dec 16, 2013, 16:30 ET

Veracyte Announces Cigna Coverage for the Afirma® Gene Expression Classifier

 Veracyte, Inc. (Nasdaq: VCYT), a molecular diagnostics company pioneering the field of molecular cytology, today announced that Cigna, one...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

Research and Markets
ReportBuyer
Investor-Edge